ORPHA:183
Eosinophilic granulomatosis with polyangiitis
Also known as: Churg-Strauss syndrome · EGPA · Granulomatous allergic angiitis
Publications
10,278
95.2th percentile
Trials
30
Interventional, condition-specific
Researchers
1,169
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare systemic vasculitis of small vessels characterized by asthma, blood and tissue eosinophilia and vasculitis manifestations.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015943
- MeSH:D015267
- UMLS:C0008728
- NCIT:C34481
Additional Mondo synonyms (35)
CSS · Churg Strauss Syndrome · Churg Strauss syndrome · Churg-Strauss vasculitis · allergic angiitides · allergic angiitides, granulomatous · allergic angiitis · allergic angiitis and granulomatosis · allergic angiitis, granulomatous · allergic granulomatoses · allergic granulomatosis · allergic granulomatous Angiitides · allergic granulomatous and angiitis · allergic granulomatous angiitis · angiitides, allergic · angiitides, allergic granulomatous · angiitides, granulomatous allergic · angiitis, allergic · angiitis, allergic granulomatous · angiitis, granulomatous allergic · eosinophilic granulomatous Vasculitides · eosinophilic granulomatous vasculitis · granulomatoses, allergic · granulomatosis, allergic · granulomatous allergic Angiitides · granulomatous allergic angiitis · granulomatous angiitides, allergic · granulomatous angiitis, allergic · granulomatous vasculitides, eosinophilic · granulomatous vasculitis, eosinophilic · syndrome, Churg-Strauss · vasculitides, eosinophilic granulomatous · vasculitis, Churg Strauss · vasculitis, Churg-Strauss · vasculitis, eosinophilic granulomatous
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
10,278 matched papers (5,841 in last 10 years) Source
- Phenotype characterisedPresent
68 HPO annotations (e.g. Asthma; Central nervous system degeneration; Hypertension) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPresent
4 FDA · 2 EMA designations (2 FDA orphan-indication approvals) — e.g. benralizumab Source
- Interventional trialPresent
30 matched on ClinicalTrials.gov (6 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
68
Associated phenotypes · MONDO:0015943
- Asthma
- Central nervous system degeneration
- Hypertension
- Gait disturbance
- Abnormal pleura morphology
Showing 5 of 68 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
6
Designations · 2 with FDA orphan-indication approval
- FDA benralizumabEosinophilic granulomatosis with polyangiitis · 2018-11-21 · Not FDA Approved for Orphan Indication
- FDA avacopanChurg-Strauss Syndrome Vasculitides Microscopic Polyangiitis Granulomatosis with polyangiitis Wegener Granulomatosis · 2014-06-02 · Not FDA Approved for Orphan Indication
- EMA Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate mono(4-methylbenzenesulfonate)Treatment of eosinophilic granulomatosis with polyangiitis · 12/01/2024 · PositiveEMA designation
- FDA mepolizumab (NUCALA)Churg-Strauss Syndrome · 2011-07-14
- FDA rituximab (Rituxan)Churg-Strauss Syndrome Microscopic Polyangiitis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Wegener's Granulomatosis · 2006-02-14
- EMA MepolizumabTreatment of Churg-Strauss syndrome · 12/03/2013 · WithdrawnEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
19
Drugs / clinical candidates · MONDO_0015943
- AZATHIOPRINE·phase 3
- BENRALIZUMAB·phase 3
- BETAMETHASONE·phase 3
- BETAMETHASONE SODIUM PHOSPHATE·phase 3
- CYCLOPHOSPHAMIDE·phase 3
- DEPEMOKIMAB·phase 3
- DEXAMETHASONE·phase 3
- HYDROCORTISONE·phase 3
- MEPOLIZUMAB·phase 3
- METHYLPREDNISOLONE·phase 3
- PREDNISOLONE·phase 3
- PREDNISONE·phase 3
- RITUXIMAB·phase 3
- TRIAMCINOLONE·phase 3
- AVACOPAN·phase 2
CTD chemicals (MyDisease.info)
19 associated chemicals. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Adrenal Cortex Hormones · therapeutic
- Azathioprine · therapeutic
- Cortisone · therapeutic
- Cyclophosphamide · therapeutic
- Methylprednisolone · therapeutic
- Prednisolone · therapeutic
- Prednisone · therapeutic
- Steroids · therapeutic
- Acetaminophen · marker/mechanism
- Azithromycin · marker/mechanism
- Carbamazepine · marker/mechanism
- Carbimazole · marker/mechanism
Literature
Is anyone studying this?
10,278
10,278 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
10,278 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
5,841 in the last 10 years · medium confidence · 95.2th percentile (publications denominator)
Phrase hits: 10,278 · MeSH hits: 0
Who's working on it?
1,169
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Wechsler ME10 papers · 2026
Department of Medicine, National Jewish Health, Denver, Colorado.
Papers in Europe PMC - 02Hellmich B8 papers · 2026
Klinik für Innere Medizin, Rheumatologie, Pneumologie, Nephrologie und Diabetologie, Medius Kliniken, Akademisches Lehrkrankenhaus der Universität Tübingen, Kirchheim unter Teck, Germany.
Papers in Europe PMC - 03Emmi G7 papers · 2026
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Papers in Europe PMC - 04
- 05Vaglio A7 papers · 2026
Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
Papers in Europe PMC - 06Higuchi T5 papers · 2026
Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Papers in Europe PMC - 07Merkel PA5 papers · 2026
Division of Rheumatology, Department of Medicine, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
Papers in Europe PMC - 08Pagnoux C5 papers · 2026
Mount Sinai Hospital, University Health Network, Toronto, ON, Canada.
Papers in Europe PMC - 09Tamura N5 papers · 2026
Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Japan.
Papers in Europe PMC - 10Tanaka K5 papers · 2026
Nephrology and Rheumatology center, and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, 105-8470, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
30
interventional trials for this specific condition
30 interventional trials matched this specific condition name; 6 currently recruiting in our sample. 25 trials are registered for granulomatosis with polyangiitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
30 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 96th percentile).
medium confidence · 96th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
30 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07343661·ENROLLING BY INVITATION·Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
Not reviewed·Conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis · Severe Asthma · Eosinophilic Asthma·Matched via name phrase
- NCT07444567·NOT YET RECRUITING·Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Not reviewed·Conditions: Asthma · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilic Syndrome (HES)·Matched via name phrase
- NCT02947945·RECRUITING·Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Not reviewed·Conditions: Asthma·Matched via name phrase
- NCT05979051·RECRUITING·A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Not reviewed·Conditions: Eosinophilic Granulomatosis With Polyangiitis·Matched via name phrase
- NCT06512883·RECRUITING·A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Not reviewed·Conditions: Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilia Syndrome (HES)·Matched via name phrase
- NCT07275190·RECRUITING·The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Not reviewed·Conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis · HES - Hypereosinophilic Syndrome·Matched via name phrase
Broader category: granulomatosis with polyangiitis
25
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07176546·NOT YET RECRUITING·TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Not reviewed·Conditions: Granulomatosis With Polyangiitis · Wegener's · GPA·Matched via name phrase
- NCT07087912·RECRUITING·Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not reviewed·Conditions: Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE) · Juvenile Systemic Lupus Erythematosus·Matched via name phrase
- NCT06983821·RECRUITING·Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
Not reviewed·Conditions: Granulomatosis With Polyangiitis · Microscopic Polyangiitis (MPA)·Matched via name phrase
- NCT06940661·RECRUITING·Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
Not reviewed·Conditions: Granulomatosis With Polyangiitis·Matched via name phrase
- NCT04871191·RECRUITING·Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
Not reviewed·Conditions: Granulomatosis With Polyangiitis · Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis·Matched via name phrase
- NCT06581562·RECRUITING·Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Not reviewed·Conditions: Rheumatoid Arthritis · Pemphigus Vulgaris · Granulomatosis With Polyangiitis · Systemic Lupus Erythematosus·Matched via name phrase
- NCT07451847·NOT YET RECRUITING·Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
Not reviewed·Conditions: ANCA Associated Vasculitis (AAV) · Polyangiitis (GPA) · Microscopic Polyangiitis (MPA)·Matched via name phrase
Observational and natural-history studies
26 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06911775·NOT YET RECRUITING·Eosinophil Subpopulations in Eosinophilic-associated Diseases
Not reviewed·Conditions: Eosinophilic Asthma · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilic Syndrome (HES)·Matched via name phrase
- NCT00315380·RECRUITING·Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
Not reviewed·Conditions: Eosinophilic Granulomatosis With Polyangiitis · Churg-Strauss Syndrome·Matched via name phrase
- NCT07664709·RECRUITING·Ocular Manifestations of Granulomatosis With Polyangiitis.
Not reviewed·Conditions: GPA · Vasculitis · Microscopic Polyangiitis (MPA) · Churg-Strauss Syndrome (CSS)·Matched via name phrase
- NCT02593565·RECRUITING·Vasculitis Pregnancy Registry
Not reviewed·Conditions: Vasculitis · Behcet's Disease · CNS Vasculitis · Cryoglobulinemic Vasculitis·Matched via name phrase
- NCT03004326·RECRUITING·Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Not reviewed·Conditions: Cryoglobulinemic Vasculitis (CV) · Drug-induced Vasculitis · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · IgA Vasculitis·Matched via name phrase
- NCT02967068·RECRUITING·VCRC Tissue Repository
Not reviewed·Conditions: Aortitis · Cutaneous Vasculitis · Eosinophilic Granulomatosis With Polyangiitis · Giant Cell Arteritis·Matched via name phrase
- NCT04538937·RECRUITING·Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
Not reviewed·Conditions: Eosinophilic Asthma · EGPA - Eosinophilic Granulomatosis With Polyangiitis · Samter Triad · HES - Hypereosinophilic Syndrome·Matched via name phrase
- NCT01241305·RECRUITING·One-Time DNA Study for Vasculitis
Not reviewed·Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) · Giant Cell Arteritis · Granulomatosis With Polyangiitis (Wegener's) · Microscopic Polyangiitis·Matched via name phrase
- NCT06298448·RECRUITING·eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Not reviewed·Conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 13 · after dedupe 13 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 13 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (13)
- ctis·2023-508533-14-00·Authorised·Phase III, Open-label Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, Efficacy, and Immunogenicity of Benralizumab in Children with Eosinophilic Disease (CLIPS)
skipped — LLM skipped (--skip-llm)
- ctis·2024-514794-22-01·11·A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE
skipped — LLM skipped (--skip-llm)
- ctis·2024-513653-75-00·Cancelled·E-merge - Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study
skipped — LLM skipped (--skip-llm)
- ctis·2023-510019-20-00·Expired·A 52-week, randomized, double-blind, double-dummy, parallel-group, multi-centre, non-inferiority study to investigate the efficacy and safety of depemokimab compared with mepolizumab in adults with relapsing or refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA) receiving standard of care (SoC) therapy
skipped — LLM skipped (--skip-llm)
- ctis·2023-510248-19-00·Expired·A Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy (MANDARA Study).
skipped — LLM skipped (--skip-llm)
- ctis·2023-504245-32-00·Authorised, recruiting·A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
skipped — LLM skipped (--skip-llm)
- ctis·2023-508029-28-00·Authorised, ongoing·eGPA and local inflammation within the ENT area; Impact of Mepolizumab treatment on the nasal microbiome and local and systemic immune response in eosinophilic granulomatosis with polyangitis (eGPA)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17701271·Not yet recruiting·129Xenon MRI study of the effects of Mepolizumab on inflammation in the lungs of patients with chronic obstructive pulmonary disease (COPD)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79334891·No longer recruiting·Hydroxychloroquine in ANCA Vasculitis Evaluation (HAVEN)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18210817·No longer recruiting·Measuring response to inhaled asthma therapy using pulmonary imaging
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN28528813·No longer recruiting·An international, randomised, open label trial comparing a rituximab-based regimen with a standard cyclophosphamide/azathioprine based regimen in the treatment of active, generalised anti-neutrophilic cytoplasmic antibodies associated vasculitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN03001669·No longer recruiting·European Community SYStemic VASculitis TRIALs group
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36285326·Stopped·The Effect of Exercise Training and Psychological Support in Patients With Small Vessel Vasculitis: a Randomised Crossover Study
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Eosinophilic granulomatosis with polyangiitis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Eosinophilic granulomatosis with polyangiitis" OR "Churg-Strauss syndrome" OR "Granulomatous allergic angiitis" OR "Churg Strauss Syndrome" OR "Churg-Strauss vasculitis" OR "allergic angiitides" OR "allergic angiitides, granulomatous" OR "allergic angiitis" OR "allergic angiitis and granulomatosis" OR "allergic angiitis, granulomatous" OR "allergic granulomatoses" OR "allergic granulomatosis" OR "allergic granulomatous Angiitides" OR "allergic granulomatous and angiitis" OR "allergic granulomatous angiitis" OR "angiitides, allergic" OR "angiitides, allergic granulomatous" OR "angiitides, granulomatous allergic" OR "angiitis, allergic" OR "angiitis, allergic granulomatous" OR "angiitis, granulomatous allergic" OR "eosinophilic granulomatous Vasculitides" OR "eosinophilic granulomatous vasculitis" OR "granulomatoses, allergic" OR "granulomatosis, allergic" OR "granulomatous allergic Angiitides" OR "granulomatous angiitides, allergic" OR "granulomatous angiitis, allergic" OR "granulomatous vasculitides, eosinophilic" OR "granulomatous vasculitis, eosinophilic" OR "syndrome, Churg-Strauss" OR "vasculitides, eosinophilic granulomatous" OR "vasculitis, Churg Strauss" OR "vasculitis, Churg-Strauss" OR "vasculitis, eosinophilic granulomatous")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Eosinophilic granulomatosis with polyangiitis" OR "Churg-Strauss syndrome" OR "Granulomatous allergic angiitis" OR "Churg Strauss Syndrome" OR "Churg-Strauss vasculitis" OR "allergic angiitides" OR "allergic angiitides, granulomatous" OR "allergic angiitis" OR "allergic angiitis and granulomatosis" OR "allergic angiitis, granulomatous" OR "allergic granulomatoses" OR "allergic granulomatosis" OR "allergic granulomatous Angiitides" OR "allergic granulomatous and angiitis" OR "allergic granulomatous angiitis" OR "angiitides, allergic" OR "angiitides, allergic granulomatous" OR "angiitides, granulomatous allergic" OR "angiitis, allergic" OR "angiitis, allergic granulomatous" OR "angiitis, granulomatous allergic" OR "eosinophilic granulomatous Vasculitides" OR "eosinophilic granulomatous vasculitis" OR "granulomatoses, allergic" OR "granulomatosis, allergic" OR "granulomatous allergic Angiitides" OR "granulomatous angiitides, allergic" OR "granulomatous angiitis, allergic" OR "granulomatous vasculitides, eosinophilic" OR "granulomatous vasculitis, eosinophilic" OR "syndrome, Churg-Strauss" OR "vasculitides, eosinophilic granulomatous" OR "vasculitis, Churg Strauss" OR "vasculitis, Churg-Strauss" OR "vasculitis, eosinophilic granulomatous"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 30 interventional · 26 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"granulomatosis with polyangiitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: EGPA; CSS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T12:48:06.321Z
